Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ARICEPT 23 MG TABLET

donepezil hydrochloride
$14.3864per EA
High Outlier

Strength

23 mg/1

Manufacturer

Eisai Inc.

NDC

62856024730

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

DONEPEZIL HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022568

On Market Since

7/23/2010

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-0.2%

5Y

-0.2%

All

+42.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MESTINON 60 MG/5 ML SYRUP
Brand
00187301220•Bausch Health US LLC
$1.9930
per ML
NAMZARIC 21 MG-10 MG CAPSULE
Brand
00456122130•Allergan, Inc.
$19.7649
per EA
NAMZARIC 28 MG-10 MG CAPSULE
Brand
00456122830•Allergan, Inc.
$19.8156
per EA
NAMZARIC 7 MG-10 MG CAPSULE
Brand
00456120730•Allergan, Inc.
$19.8250
per EA
NAMZARIC 14 MG-10 MG CAPSULE
Brand
00456121430•Allergan, Inc.
$19.8307
per EA
MESTINON 60 MG TABLET
Brand
00187301030•Bausch Health US LLC
$20.7334
per EA
EXELON 9.5 MG/24HR PATCH
Brand
00078050215•Novartis Pharmaceuticals Corporation
$21.5451
per EA
EXELON 9.5 MG/24HR PATCH
Brand
66758014331•Sandoz Inc.
$21.5451
per EA
EXELON 4.6 MG/24HR PATCH
Brand
00078050115•Novartis Pharmaceuticals Corporation
$21.9387
per EA
EXELON 4.6 MG/24HR PATCH
Brand
66758014231•Sandoz Inc.
$21.9387
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy